Sandra Molina
Geschäftsführer bei PHARMA-BIO SERV, INC.
Aktive Positionen von Sandra Molina
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PHARMA-BIO SERV, INC. | Geschäftsführer | 01.09.2021 | - |
Karriereverlauf von Sandra Molina
Ehemalige bekannte Positionen von Sandra Molina
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | Corporate Officer/Principal | 01.01.2019 | 01.01.2021 |
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Commercial Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PHARMA-BIO SERV, INC. | Commercial Services |
Private Unternehmen | 1 |
---|---|
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | Health Technology |
- Börse
- Insiders
- Sandra Molina
- Erfahrung